pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Adzynma
drug · enzyme
save

cinaxadamtase alfa

Phase 2updated 3mo ago
by $TAK TAKEDA PHARMACEUTICAL CO LTD🔗 ChEMBL
Phase 2
community read0 votes

Enzyme drug with a maximum clinical stage of Approval, with an approval for thrombotic thrombocytopenic purpura.

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand
Adzynma
generic
cinaxadamtase alfa
indication
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 19m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?